Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Synthesis and biological activity of novel inhibitors of aminoglycoside resistance

EF 2010-11

Résumé
Antibiotics are powerful, commonly-prescribed medications used in everyday life. The problem? Antibiotic resistance. Bacteria are developing methods to inhibit antibiotic function, making it increasingly difficult to treat bacterial infections with current medications. The Auclair group investigates methods to counteract specific antibiotic resistance mechanisms of the bacteria Enterococcus faecium, a leading cause of hospital-acquired infections. The goal is to create drugs to be taken in combination with antibiotics, which prevent the effect of resistance and enable the antibiotic to act regularly. Their scientific research has enabled the development of a pharmaceutically-promising lead compound that is active in cells, but requires further optimization. This project aims to improve the potency of this drug candidate, by creating and testing a library of derivatives of the compound.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
224858
Name
Hoegl Annabelle
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Synthesis and biological activity of novel inhibitors of aminoglycoside resistance
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Enzymology; Medicinal Chemistry; Synthesis
Abstract
Antibiotics are powerful, commonly-prescribed medications used in everyday life. The problem? Antibiotic resistance. Bacteria are developing methods to inhibit antibiotic function, making it increasingly difficult to treat bacterial infections with current medications. The Auclair group investigates methods to counteract specific antibiotic resistance mechanisms of the bacteria Enterococcus faecium, a leading cause of hospital-acquired infections. The goal is to create drugs to be taken in combination with antibiotics, which prevent the effect of resistance and enable the antibiotic to act regularly. Their scientific research has enabled the development of a pharmaceutically-promising lead compound that is active in cells, but requires further optimization. This project aims to improve the potency of this drug candidate, by creating and testing a library of derivatives of the compound.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hoegl, Annabelle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~